CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.

Tissue inflammation in several autoimmune diseases, including SLE and MS, has been linked to an imbalance of IL-17-producing Th (Th17) cells and Tregs; however, the factors that promote Th17-driven autoimmunity are unclear. Here, we present evidence that the calcium/calmodulin-dependent protein kinase IV (CaMK4) is increased and required during Th17 cell differentiation. Isolation of naive T cells from a murine model of lupus revealed increased levels of CaMK4 following stimulation with Th17-inducing cytokines but not following Treg, Th1, or Th2 induction. Furthermore, naive T cells from mice lacking CaMK4 did not produce IL-17. Genetic or pharmacologic inhibition of CaMK4 decreased the frequency of IL-17-producing T cells and ameliorated EAE and lupus-like disease in murine models. Inhibition of CaMK4 reduced Il17 transcription through decreased activation of the cAMP response element modulator α (CREM-α) and reduced activation of the AKT/mTOR pathway, which is known to enhance Th17 differentiation. Importantly, silencing CaMK4 in T cells from patients with SLE and healthy individuals inhibited Th17 differentiation through reduction of IL17A and IL17F mRNA. Collectively, our results suggest that CaMK4 inhibition has potential as a therapeutic strategy for Th17-driven autoimmune diseases.

[1]  T. Rauen,et al.  cAMP Responsive Element Modulator (CREM) α Mediates Chromatin Remodeling of CD8 during the Generation of CD3+CD4−CD8− T Cells* , 2013, The Journal of Biological Chemistry.

[2]  A. Sawalha,et al.  Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. , 2013, Arthritis and rheumatism.

[3]  M. Birnbaum,et al.  Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways , 2013, Nature Immunology.

[4]  T. Mayadas,et al.  Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. , 2012, Immunity.

[5]  G. Tsokos,et al.  Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus , 2012, The Journal of Immunology.

[6]  T. Rauen,et al.  cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus , 2012, Proceedings of the National Academy of Sciences.

[7]  C. Riccardi,et al.  Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New , 2012, Clinical & developmental immunology.

[8]  A. Hirao,et al.  PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. , 2021, Cell reports.

[9]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[10]  B. Richardson,et al.  Dissecting complex epigenetic alterations in human lupus , 2012, Arthritis Research & Therapy.

[11]  G. Tsokos,et al.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. , 2011, Trends in molecular medicine.

[12]  T. Rauen,et al.  Cutting Edge: Calcium/Calmodulin-Dependent Protein Kinase Type IV Is Essential for Mesangial Cell Proliferation and Lupus Nephritis , 2011, The Journal of Immunology.

[13]  T. Rauen,et al.  cAMP-responsive Element Modulator (CREM)α Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus* , 2011, The Journal of Biological Chemistry.

[14]  T. Rauen,et al.  cAMP-responsive Element Modulator (CREM)α Protein Signaling Mediates Epigenetic Remodeling of the Human Interleukin-2 Gene , 2011, The Journal of Biological Chemistry.

[15]  T. Soderling,et al.  Analysis of CaM-kinase signaling in cells. , 2011, Cell calcium.

[16]  W. Leonard,et al.  Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages , 2011, Nature Immunology.

[17]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[18]  T. Mcclanahan,et al.  Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. , 2011, Immunity.

[19]  G. Tsokos,et al.  Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. , 2011, Arthritis and rheumatism.

[20]  G. Tsokos,et al.  Interleukin-17-producing T cells in lupus , 2010, Current opinion in rheumatology.

[21]  G. Tsokos,et al.  The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity , 2010, Journal of biomedicine & biotechnology.

[22]  V. Kuchroo,et al.  Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6–lpr/lpr Mice , 2010, The Journal of Immunology.

[23]  Roger L Redondo,et al.  Synaptic Tagging and Capture: Differential Role of Distinct Calcium/Calmodulin Kinases in Protein Synthesis-Dependent Long-Term Potentiation , 2010, The Journal of Neuroscience.

[24]  J. Smolen,et al.  Treg and lupus , 2009, Annals of the rheumatic diseases.

[25]  G. Tsokos,et al.  The Role of IL-23/IL-17 Axis in Lupus Nephritis1 , 2009, The Journal of Immunology.

[26]  G. Tsokos,et al.  Interleukin‐17 and systemic lupus erythematosus: current concepts , 2009, Clinical and experimental immunology.

[27]  F. Nestle,et al.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.

[28]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[29]  T. Weichhart,et al.  The multiple facets of mTOR in immunity. , 2009, Trends in immunology.

[30]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[31]  Jianping Jin,et al.  Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. , 2009, Clinical immunology.

[32]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[33]  A. Means,et al.  Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller. , 2008, Trends in immunology.

[34]  H. Wekerle.  Lessons from multiple sclerosis: models, concepts, observations , 2008, Annals of the rheumatic diseases.

[35]  Wei Liu,et al.  Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis , 2008, Arthritis research & therapy.

[36]  C. Lam,et al.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. , 2008, Clinical immunology.

[37]  L. Wedderburn,et al.  Interleukin-17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers , 2008, Arthritis and rheumatism.

[38]  Robert W. Williams,et al.  Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.

[39]  Sandra D'Alfonso,et al.  Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[40]  D. Bumcrot,et al.  Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival , 2007, Cancer biology & therapy.

[41]  L. Hennighausen,et al.  Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.

[42]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[43]  A. Perl,et al.  Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[44]  K. Mills,et al.  A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.

[45]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[46]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[47]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[48]  Peter A. Jones,et al.  Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level , 2005, Nucleic acids research.

[49]  C. Beaumont,et al.  Anemia after Late Introduction of Sirolimus May Correlate with Biochemical Evidence of a Chronic Inflammatory State , 2005, Transplantation.

[50]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[51]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[52]  C. Mawrin,et al.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.

[53]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[54]  S. Gaffen,et al.  Crucial Role for Nuclear Factor of Activated T Cells in T Cell Receptor-mediated Regulation of Human Interleukin-17* , 2004, Journal of Biological Chemistry.

[55]  W. Hörl,et al.  Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[56]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[57]  M. Nambiar,et al.  Antisense Cyclic Adenosine 5′-Monophosphate Response Element Modulator Up-Regulates IL-2 in T Cells from Patients with Systemic Lupus Erythematosus1 , 2002, The Journal of Immunology.

[58]  T. Soderling,et al.  Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway , 1998, Nature.

[59]  A. Ben-nun,et al.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.

[60]  L. Adams,et al.  Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[61]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[62]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[63]  A. Puisieux,et al.  Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2009, Nature Immunology.

[64]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.